These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
98 related items for PubMed ID: 6109080
1. Pleuropulmonary changes during long-term bromocriptine treatment for Parkinson's disease. Lancet; 1981 Jan 03; 1(8210):44-5. PubMed ID: 6109080 [No Abstract] [Full Text] [Related]
2. [Pleural effusion and constrictive pericarditis secondary to bromocriptine treatment]. Saura J, Aguilar M, Alió J. Neurologia; 1991 Nov 03; 6(9):331-3. PubMed ID: 1809340 [Abstract] [Full Text] [Related]
5. Pleuropulmonary changes during treatment of Parkinson's disease with a long-acting ergot derivative, cabergoline. Frans E, Dom R, Demedts M. Eur Respir J; 1992 Feb 03; 5(2):263-5. PubMed ID: 1348483 [Abstract] [Full Text] [Related]
6. [Pleural effusion induced by bromocriptine]. Diot E, Diot P, Le Rolland A, Jonville AP, Lasfargues G, Lemarie E, Lavandier M, Guilmot JL. Rev Mal Respir; 1990 Feb 03; 7(2):175-7. PubMed ID: 2320790 [Abstract] [Full Text] [Related]
7. [Bromocriptine and pulmonary responses]. Kinnunen E, Viljanen A. Duodecim; 1989 Feb 03; 105(19):1614-7. PubMed ID: 2806146 [No Abstract] [Full Text] [Related]
8. Pleuropulmonary disease during bromocriptine treatment of Parkinson's disease. McElvaney NG, Wilcox PG, Churg A, Fleetham JA. Arch Intern Med; 1988 Oct 03; 148(10):2231-6. PubMed ID: 3178380 [Abstract] [Full Text] [Related]
10. [Bromocriptine in Parkinson's disease: pleuropulmonary toxicity]. Douvier JJ, Vergeret J, Taytard A, Brottier E, Domblides P, Dubos F, Freour P. Ann Med Interne (Paris); 1985 Oct 03; 136(5):416-8. PubMed ID: 4062141 [Abstract] [Full Text] [Related]
11. Sustained bromocriptine therapy in 50 previously untreated patients with Parkinson's disease. Stern GM, Lees AJ. Adv Neurol; 1983 Oct 03; 37():17-21. PubMed ID: 6858771 [Abstract] [Full Text] [Related]
12. Pleuropulmonary fibrosis due to bromocriptine treatment for Parkinson's disease. Todman DH, Oliver WA, Edwards RL. Clin Exp Neurol; 1990 Oct 03; 27():79-82. PubMed ID: 2129961 [Abstract] [Full Text] [Related]
13. Chronic constrictive pericarditis induced by long-term bromocriptine therapy: report of two cases. Champagne S, Coste E, Peyrière H, Nigond J, Mania E, Pons M, Hillaire-Buys D, Balmes P, Blayac JP, Davy JM. Ann Pharmacother; 1999 Oct 03; 33(10):1050-4. PubMed ID: 10534217 [Abstract] [Full Text] [Related]
14. [Pleuropneumopathy caused by bromocriptine in a patient with Parkinson disease. Review of the literature apropos of a new case]. Debove P, Simon F, Vaylet F, Renard JL, L'Her P. Ann Med Interne (Paris); 1998 Apr 03; 149(3):167-71. PubMed ID: 11490541 [Abstract] [Full Text] [Related]
17. Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease. Grimes JD, Delgado MR. Clin Neuropharmacol; 1985 Apr 03; 8(1):73-7. PubMed ID: 3978651 [Abstract] [Full Text] [Related]
18. [Bromocriptine as the 1st treatment of Parkinson's disease. Long term results]. Rascol A, Montastruc JL, Guiraud-Chaumeil B, Clanet M. Rev Neurol (Paris); 1982 Apr 03; 138(5):401-8. PubMed ID: 7146724 [Abstract] [Full Text] [Related]